Hormone Optimization

Tesamorelin Therapy

The premium, FDA-approved growth hormone peptide. Clinically proven to reduce visceral fat, improve cognitive function, and optimize metabolic health.

Fit person demonstrating healthy body composition from peptide therapy
FDA-Approved Peptide Licensed Providers
What is Tesamorelin?

The most clinically studied growth hormone peptide available.

Tesamorelin is a more potent GHRH analog — FDA-approved (brand name: Egrifta) and clinically proven to reduce visceral fat. It's the premium option for patients who want the strongest evidence-backed growth hormone peptide available.

Tesamorelin has more published clinical data than almost any other peptide on the market, with multiple peer-reviewed studies demonstrating significant effects on body composition, cognitive function, and metabolic markers.

Benefits

What tesamorelin can do for you.

Backed by clinical trials and peer-reviewed research.

Visceral Fat Reduction

Significant reduction in belly fat, particularly the dangerous visceral fat around organs. Clinically demonstrated in multiple trials.

Cognitive Enhancement

Emerging research shows neuroprotective properties. Patients report improved mental clarity and focus.

Metabolic Health

Enhanced lipid metabolism and improved metabolic markers. Supports healthier cholesterol and triglyceride levels.

Body Composition

All the benefits of growth hormone optimization — lean muscle, recovery, skin quality — with the added fat-targeting advantage.

How It Works

A smarter path to growth hormone optimization.

Tesamorelin is a growth hormone-releasing hormone (GHRH) analog — similar to sermorelin, but more potent. Like sermorelin, it works by stimulating your pituitary gland to produce and release growth hormone naturally, preserving your body's feedback loops and pulsatile release patterns.

What sets tesamorelin apart is its enhanced potency and its FDA approval specifically for reducing visceral adipose tissue. It has the most published clinical data of almost any peptide on the market, making it the gold standard for evidence-based GH optimization.

How it's used: Daily subcutaneous injection, typically administered in the morning or evening. Most patients commit to a minimum of 3-6 months for full results. Your provider will design the dosing protocol around your labs and goals.
Comparison

Tesamorelin vs. Sermorelin

Both are GHRH analogs that stimulate natural growth hormone production. Here's how they compare.

Sermorelin

The effective, affordable standard option. Decades of safety data, well-studied for sleep, recovery, and overall GH optimization. A great starting point for most patients.

Learn about Sermorelin

Tesamorelin

The premium choice. FDA-approved with stronger visceral fat reduction data and emerging cognitive benefits. More potent, more clinical evidence, higher cost. Best for patients prioritizing fat loss and metabolic optimization.

Not sure which is right for you? Your provider will recommend the best option based on your labs, goals, and budget.

Ready to try Tesamorelin?

Book a free consultation and your provider will determine if tesamorelin is the right fit for your goals.

Book Free Consultation
FAQ

Common questions about tesamorelin.

Both are GHRH analogs that stimulate your pituitary gland to produce growth hormone naturally. Tesamorelin is more potent, carries FDA approval (as Egrifta), and has stronger clinical data specifically for visceral fat reduction and cognitive function. Sermorelin is the effective, affordable option; tesamorelin is the premium, evidence-backed upgrade.

Yes. Tesamorelin was FDA-approved under the brand name Egrifta for the reduction of excess abdominal fat in HIV-associated lipodystrophy. As a compounded peptide, it can be prescribed off-label by licensed providers for growth hormone optimization in appropriate patients.

Many patients notice improved sleep quality and energy within the first 2-4 weeks. Measurable changes in body composition — particularly visceral fat reduction — typically become apparent at 8-12 weeks. Full optimization generally occurs over 3-6 months of consistent use.

Tesamorelin is generally well-tolerated. The most common side effects include mild injection site reactions (redness, itching), joint pain, and peripheral edema. These are typically mild and transient. Your provider will monitor you throughout treatment and adjust as needed.

Yes. Baseline labs are required before starting tesamorelin to assess your current hormone levels, metabolic markers, and overall health. Your provider will order the appropriate panels and may request follow-up labs at 8-12 weeks to track progress and optimize dosing.

Related Treatments

Explore other protocols.

Treatments that pair well with tesamorelin or target different goals.

Fitness and hormone optimization

Sermorelin

The effective, affordable GHRH analog. Decades of safety data for sleep, recovery, and growth hormone optimization.

Learn More
Couple representing sexual wellness

PT-141

Restore desire and performance for men and women. Works through your brain's arousal pathways, not just blood flow.

Learn More
Energy and longevity

NAD+

The cellular fuel your body runs on. Injectable NAD+ supports mental clarity, sustained energy, and cellular repair.

Learn More

Ready to optimize?

Book your free consultation and your provider will build a personalized protocol based on your goals — not a one-size-fits-all menu.

Get Started — Free Consultation
Book Free Consultation